Prosecution Insights
Last updated: November 04, 2026

Synbiotic Health, Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Synbiotic Health, Inc. currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This prosecution is handled by a distinct examiner and is situated within 1 distinct art unit. This reflects a specific technical concentration for the company's current filings. Having a single point of contact at the office allows for a highly focused prosecution strategy tailored to the specific requirements of the assigned group.

The busiest examiner for the portfolio is OGUNBIYI, OLUWATOSIN A, who is responsible for 1 pending office action. This constitutes the entirety of the company's pending workload. Having only one distinct examiner and one distinct art unit means the prosecution process is highly focused. Practitioners should analyze the individual tendencies of OGUNBIYI, OLUWATOSIN A and the specific requirements of the art unit.

The presence of the pending office action in the Biotechnology & Pharmaceuticals area indicates a targeted filing strategy. Success will depend on a deep understanding of the art unit's prior art landscape and the examiner's past behavior. This focused approach is common for entities with specialized innovations in the pharmaceutical sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
OGUNBIYI, OLUWATOSIN A 1 63.8% +41.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18745165 GABA-PRODUCING GASTROINTESTINAL BACTERIA FOR SUPPORT OF MENTAL HEALTH OGUNBIYI, OLUWATOSIN A —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18745165 GABA-PRODUCING GASTROINTESTINAL BACTERIA FOR SUPPORT OF MENTAL HEALTH OGUNBIYI, OLUWATOSIN A —

Top Art Units

Art UnitApps
1645 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18745165 GABA-PRODUCING GASTROINTESTINAL BACTERIA FOR SUPPORT OF MENTAL HEALTH OGUNBIYI, OLUWATOSIN A 1645 §102§103 Non-Final OA — Pending Jun 17, 2024

Managing Synbiotic Health, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Synbiotic Health, Inc. have?

Synbiotic Health, Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Synbiotic Health, Inc. applications?

Oluwatosin A Ogunbiyi has the most, with 1 of Synbiotic Health, Inc.'s pending office actions.

What technology area are Synbiotic Health, Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month